Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.
Source link
Pfizer boosts profit estimate, even as the drug giant absorbs tariffs
You May Also Like
More From Author
How Are Wisconsin Exports, Manufacturing Doing under Trump Trade War 2.0?
